ACIDE CARGLUMIQUE WAYMADE 200 mg, dispersible tablet 60 tablets, CIP 3400955052227
Active ingredients: Carglumic acid
Commercialized according to BDPMDispensing in France: Prescription only
Dispersible tablet60 tablets, CIP 3400955052227orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ACIDE CARGLUMIQUE WAYMADE 200 mg, comprimé dispersible
- Pharmaceutical form
- comprimé dispersible
- Route of administration
- orale
- Presentation description
- 1 pilulier(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 60 comprimé(s)
- Marketing authorisation holder
- WAYMADE (PAYS-BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 23 May 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63501366CIP75505222CIP133400955052227Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACIDE CARGLUMIQUEcomprimé | 200 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.